Remnant lipoprotein is a residual risk of future cardiovascular events in patients with stable coronary artery disease and on statin LDL-cholesterol levels less than 70 mg/dl
Event:
ESC Congress 2019
Topic:
Drug therapy
Session:
How good/bad are we in treating lipids